Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6900
+0.0400 (2.42%)
NASDAQ · Last Trade: Jan 28th, 3:12 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors